CDR3 Therapeutics, Inc.

CDR3 Therapeutics, Inc.

CDR3 develops stem cell-based immunotherapies to cure HPV-related cancers using chimeric antigen receptors or chronic viral infections using T cell receptors. Market: Today, we lack cures for most virus-related cancers and chronic viral infections, especially from...
Myst Therapeutics

Myst Therapeutics

Myst Therapeutics, Inc. is developing novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to destroy solid tumor cancer cells. Market:Over 400,000 Americans die from cancer every year, with roughly 10% being blood cancers...